FDA clears AtriCure's heart device

06/14/2010 | MedCityNews.com

AtriCure has received 510(k) clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System, which prevents blood clots during cardiac procedures. The company plans a full launch of the product this year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN